Showing results (51-60 of 1,250) with videos related to
Sort By:
Pageof 125
Expert Opinion on Investigational Drugs|July 22, 2010
New small molecules for the treatment of Parkinson's diseaseThomas MüllerExpert Opinion on Drug Metabolism & Toxicology|May 7, 2013
Suitability of the adenosine antagonist istradefylline for the treatment of Parkinson's disease: pharmacokinetic and clinical considerationsThomas MüllerExpert Review of Neurotherapeutics|September 24, 2013
Current status of safinamide for the drug portfolio of Parkinson's disease therapyThomas MüllerExpert Review of Neurotherapeutics|June 7, 2013
Detoxification and antioxidative therapy for levodopa-induced neurodegeneration in Parkinson's diseaseThomas MüllerNeurology International|March 27, 2026
No New Relevant Treatment Options for L-DOPA-Induced Dyskinesia from a Clinician's Point of ViewThomas MüllerExpert Opinion on Investigational Drugs|December 9, 2016
Investigational agents for the management of Huntington's diseaseThomas MüllerTherapeutic Advances in Neurological Disorders|March 4, 2014
Tolcapone addition improves Parkinson's disease associated nonmotor symptomsThomas Müller, Expert Opinion on Pharmacotherapy|July 10, 2020
An evaluation of subcutaneous apomorphine for the treatment of Parkinson's diseaseThomas MüllerJournal of Experimental Pharmacology|April 7, 2021
Experimental Dopamine Reuptake Inhibitors in Parkinson's Disease: A Review of the EvidenceThomas MüllerThe Psychoanalytic Quarterly|April 28, 2004
On psychotic transference and countertransferenceThomas MüllerPageof 125